Concepedia

Charlene Mantia

CM

Statistics

Publications

14

Citations

708

H-Index

12

Active since

2017

Affiliations

Dana-Farber Cancer Institute(Current)

Beth Israel Deaconess Medical Center

Harvard University

Georgetown Lombardi Comprehensive Cancer Center

Bristol-Myers Squibb (United States)

Charlene Mantia is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and tumor immunology.

ORCID

Publications per year

2017–2024

14

Publications

14

Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients With Renal Cell Carcinoma

Praful Ravi, Charlene Mantia, Christopher Su et al. · JAMA Oncology · 2020 · 126 citations · Full text

, , +17

Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors

Brian J. Carney, Erik J. Uhlmann, Mäneka Puligandla et al. · Journal of Thrombosis and Haemostasis · 2018 · 117 citations

, , +16

Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin

Charlene Mantia, Erik J. Uhlmann, Mäneka Puligandla et al. · Blood · 2017 · 112 citations

, , +14

Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors

Anita Gul, Tyler F. Stewart, Charlene Mantia et al. · Journal of Clinical Oncology · 2020 · 97 citations · Full text

, , +17

The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma

Bradley A. McGregor, Guru Sonpavde, Lucia Kwak et al. · Annals of Oncology · 2023 · 86 citations · Full text

, , +15

1–5 of 14